Peer Reviewed
Ophthalmology clinic

Advances in the management of age-related macular degeneration

Tu Huynh, Erwin R Groeneveld
Abstract
New treatments are becoming available for the leading cause of legal blindness in the elderly in the western world that not only halt the progression of visual loss but may improve visual outcomes.
Key Points

    Age-related macular degeneration (ARMD) is a slowly progressive, binocular loss of central vision due to deterioration of the retinal pigment epithelium in the macula. It is the leading cause of legal blindness in adults over 65 years of age in the western world. An ongoing study has found ARMD to be the principal cause of bilateral and unilateral non-correctable blindness (visual acuity less than 6/60) in the aged population of the Blue Mountains, NSW, an area chosen for study as its demography is similar to the overall Australian population of this age.

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?